<SEC-DOCUMENT>0001213900-25-067754.txt : 20250725
<SEC-HEADER>0001213900-25-067754.hdr.sgml : 20250725
<ACCEPTANCE-DATETIME>20250725161530
ACCESSION NUMBER:		0001213900-25-067754
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250725
FILED AS OF DATE:		20250725
DATE AS OF CHANGE:		20250725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ASCENTAGE PHARMA GROUP INTERNATIONAL
		CENTRAL INDEX KEY:			0002023311
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42484
		FILM NUMBER:		251151865

	BUSINESS ADDRESS:	
		STREET 1:		68 XINQING ROAD
		STREET 2:		SUZHOU INDUSTRIAL PARK
		CITY:			SUZHOU , JIANGSU
		STATE:			F4
		ZIP:			00000
		BUSINESS PHONE:		86 512 8555 7777

	MAIL ADDRESS:	
		STREET 1:		68 XINQING ROAD
		STREET 2:		SUZHOU INDUSTRIAL PARK
		CITY:			SUZHOU , JIANGSU
		STATE:			F4
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0250251-6k_ascentage.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Washington,
D.C. 20549 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Form
6-K </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Rule 13a-16 or 15d-16</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>under the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of <B>July 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number: 001-42484</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASCENTAGE PHARMA GROUP INTERNATIONAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Translation of Registrant&rsquo;s name into
English)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>68 Xinqing Road</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Suzhou Industrial Park</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Suzhou, Jiangsu</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>China</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F &#9746; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 25, 2025, Ascentage
Pharma Group International issued an announcement entitled, &ldquo;Closing of Placing of Existing Shares and Top-Up Subscription of New
Shares Under General Mandate&rdquo;. A copy of the announcement is furnished as Exhibit 99.1 to this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEX TO EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: left; vertical-align: bottom; width: 9%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
 Number</B>&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: left; vertical-align: bottom; width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Title</B></FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A HREF="ea025025101ex99-1_ascentage.htm">Announcement dated July 25, 2025</A></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1.1pt">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASCENTAGE PHARMA GROUP INTERNATIONAL</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1.1pt; width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 1.1pt; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July 25, 2025</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Dajun Yang</I></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1.1pt">&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="padding-left: 1.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Dajun Yang</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 1.1pt">&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="padding-left: 1.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<I>&nbsp;</I></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea025025101ex99-1_ascentage.htm
<DESCRIPTION>ANNOUNCEMENT DATED JULY 25, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Hong Kong Exchanges and Clearing Limited and
The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its
accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole
or any part of the contents of this announcement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This announcement is for information purposes
only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities of the Company.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Neither this announcement nor any copy thereof
may be released into or distributed directly or indirectly in the United States or any other jurisdiction where such release or distribution
might be unlawful.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This announcement does not constitute or form
a part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities mentioned herein have
not been, and will not be, registered under the U.S. Securities Act, and may not be offered or sold in the United States or to U.S. persons
(as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act or pursuant to an exemption
from, or in a transaction not subject to, registration under the U.S. Securities Act. The Company has no intention to register under the
U.S. Securities Act any of the securities referred to herein or to conduct a public offering of securities in the United States, Hong
Kong (&ldquo;public&rdquo; within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance, Chapter 32 of the
Laws of Hong Kong) or elsewhere.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASCENTAGE PHARMA GROUP INTERNATIONAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&#20126;&#30427;&#37291;&#34277;&#38598;&#22296;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Incorporated in the Cayman Islands with limited
liability)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Stock Code: 6855)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLOSING OF PLACING OF EXISTING SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TOP-UP SUBSCRIPTION OF NEW SHARES UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GENERAL MANDATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Joint Overall Coordinators and Capital Markets
Intermediaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Joint Placing Agents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reference is made to the announcement of Ascentage
Pharma Group International (the &ldquo;<B>Company</B>&rdquo;) dated July 14, 2025 in relation to the placing of the existing Shares and
top-up subscription of new Shares under the General Mandate (the &ldquo;<B>Top-up Placing Announcement</B>&rdquo;). Unless otherwise defined,
capitalized terms used herein shall have the same respective meanings as those defined in the Top-up Placing Announcement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board is pleased to announce that all the
Placing Conditions Precedent have been satisfied and the closing of the Placing took place on July 17, 2025. An aggregate of 22,000,000
Sale Shares have been successfully placed by the Placing Agents to not less than six Placees at the Placing Price of HK$68.60 per Sale
Share pursuant to the terms and conditions of the Placing and Subscription Agreement. To the best of the Directors&rsquo; knowledge, information
and belief and having made all reasonable enquiries, the Placees and their respective ultimate beneficial owners are third parties independent
of the Company and its connected persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As all the Subscription Conditions Precedent have
also been fulfilled, the Company allotted and issued 22,000,000 Subscription Shares (being the same number as the Sale Shares) to the
Vendor at HK$68.60 per Subscription Share (being the same as the Placing Price) on July 25, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net proceeds arising from the Subscription
amount to approximately HK$1,492.5 million. The net proceeds from the Subscription are expected to be used for (i) commercialization efforts,
including expanding coverage and improving patient access; (ii) global clinical development to advance the core pipeline candidates of
the Company; and (iii) infrastructure and working capital to strengthen global operations. Please refer to the Top-up Placing Announcement
for further details on the use of the net proceeds from the Subscription.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Subscription Shares were issued under the
General Mandate granted to the Directors by the Shareholders at the annual general meeting of the Company held on May 19, 2025 to allot,
issue and deal with up to 69,689,796 Shares. Immediately prior to the closing of the Placing and the Subscription, no Shares have been
issued by the Company pursuant to the General Mandate. Following the closing of the Placing and the Subscription, the Company may still
allot, issue and deal with up to 47,689,796 Shares pursuant to the General Mandate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>EFFECT OF THE PLACING AND THE SUBSCRIPTION
ON SHAREHOLDING STRUCTURE OF THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shareholding structure of the Company (i)
immediately prior to the closing of the Placing and the Subscription; (ii) immediately after the closing of the Placing but before the
closing of the Subscription; and (iii) immediately after the closing of the Placing and the Subscription (assuming there is no change
in the issued share capital of the Company between the date of the Placing and Subscription Agreement and the closing of the Placing and
the Subscription, other than the Placing and the Subscription pursuant to the Placing and Subscription Agreement) are set out below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Shareholder</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Immediately prior to <BR>
the closing of the Placing<BR>
 and the Subscription</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Immediately after the<BR> closing of the Placing but<BR>
 before the closing of <BR>
the Subscription</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Immediately after <BR>
the closing of the Placing<BR>
 and the Subscription</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-style: italic; text-align: center">Number of <BR>
Shares held</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-style: italic">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-style: italic; text-align: center">Approximate <BR>
percentage <BR>
of total <BR>
Shares in <BR>
issue</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-style: italic">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-style: italic; text-align: center">Number of <BR>
Shares held</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-style: italic">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-style: italic; text-align: center">Approximate<BR>
 percentage <BR>
of total <BR>
Shares in <BR>
issue</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-style: italic">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-style: italic; text-align: center">Number of<BR>
 Shares held</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-style: italic">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-style: italic; text-align: center">Approximate <BR>
percentage <BR>
of total <BR>
Shares in <BR>
issue</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-style: italic">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: bottom; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: left">Substantial Shareholders</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;Dr. Zhai SPV<SUP>(1)(2)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">60,665,461</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">17.34</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">38,665,461</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">11.05</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">60,665,461</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">16.31</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;Dr. Yang<SUP>(2)(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.34</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.05</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.31</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;Dr. Wang<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.34</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.05</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.31</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;Dr. Guo<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.34</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.05</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.31</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ndash;Dr. Zhai<SUP>(1)(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.34</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.05</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,665,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.31</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The Vendor<SUP>(3)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,054,131</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.30</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,131</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.02</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,054,131</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.93</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: left">The Placees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.29</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.92</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; font-weight: bold; text-align: left">Other Shareholders</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">289,188,014</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">82.66</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">289,188,014</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">82.66</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">289,188,014</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">77.77</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; vertical-align: bottom; font-weight: bold; text-align: left">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">349,853,475</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.00</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">349,853,475</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.00</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">371,853,475</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.00</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><I>Notes:</I></TD><TD STYLE="text-align: left"></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.3pt; text-align: justify; text-indent: -28.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Dr. Zhai SPV is beneficially owned by (i) Dr. Zhai (3%) and (ii) the Zhai Family Trust (97%). The Zhai
Family Trust was established by Dr. Zhai as settlor for the benefits of her family members. South Dakota Trust is the trustee of the Zhai
Family Trust. Dr. Zhai is also a director of Dr. Zhai SPV.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.3pt; text-align: justify; text-indent: -28.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Dr. Yang, Dr. Guo, Dr. Wang, Dr. Zhai, Founders SPV and Dr. Zhai SPV are parties to the Concert Party
Confirmation Deed, according to which they have been and will be actively cooperating, communicating and acting in concert with each other
with respect to their interests in, and the business of, the Company and the relevant members of the Group since December 5, 2016 and
will continue to act in concert after Listing. Accordingly, each of them is deemed to be interested in an aggregate of approximately 17.34%
shareholding interest in the Company immediately prior to the closing of the Placing and the Subscription and an aggregate of approximately
16.31% shareholding interest in the Company immediately after the closing of the Placing and the Subscription.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.3pt; text-align: justify; text-indent: -28.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">The number of shares held by Dr. Yang has included the number of shares held by the Vendor which is a
discretionary family trust established by Dr. Yang as settlor for the benefits of Dr. Yang&rsquo;s family members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.3pt; text-align: justify; text-indent: -28.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">The percentage of total Shares in issue may not add up to 100% due to rounding.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cautionary Statement required by Rule 18A.05
of the Listing Rules:</B> The Company cannot guarantee that it will be able to develop, or ultimately market, any of the products in its
pipeline successfully. Shareholders and potential investors are advised to exercise due care when dealing in the securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 283.45pt; text-align: center">By order of the Board</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 283.45pt; text-align: center"><B>Ascentage Pharma Group International</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 283.45pt; text-align: center"><B>Dr. Yang Dajun</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 283.45pt; text-align: center"><I>Chairman and Executive Director</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Suzhou, the PRC, July 25, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>As at the date of this announcement, the Board
comprises Dr. Yang Dajun as chairman and executive Director, Dr. Wang Shaomeng and Dr. Lu Simon Dazhong as non-executive Directors<SUP>Note</SUP>,
and Mr. Ye Changqing, Mr. Ren Wei, Dr. David Sidransky, Ms. Marina S. Bozilenko, Dr. Debra Yu and Marc E. Lippman, MD as independent non-executive
Directors.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><I>Note:</I></TD><TD STYLE="text-align: justify"><I>Dr. Lu Simon Dazhong is an independent director under NASDAQ rules.</I></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !5 0 # 2(  A$! Q$!_\0
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M? NB7[NL'B'Q_K\G]G>%M)D2)XYI;7[=)_:.IQP21S#1]/U&5)8S'YB^(_\
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M2S^$=#QK'B.]MX$UBXO)M4O--M8KVVLH;(2V]Q++^>G[06F_"_X'?M'ZG?\
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MO#MK?75SHGB3PYJ.L7%EIVH;[&ZBM-6TZ"Y;4+'4+2XEDMA9SV\[_J1^U?\
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MM'1]2U_5_$=GJP2?4]6U2UM+;4X;J6.WL[=[1;B\N_\ !;7X,?%'X5_LR?\
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M2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  F 64# 2(  A$! Q$!_\0
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MWK8T"*274XO#VB:=I5Y=7NL/:+:?:ULM,@G.HZA9Q/[Q_P $)_@=\1_V>_\
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M+4O#OBGX ?!O0=<L&<;MC3V%[<P%A\\,AR-KIQ_'?^R'\1OVC_\ @GW\9O\
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M5/JVJ:$=1\,1P/::@8[S7]0-WYLJFZB:*,E#$KC\&_VF?^5F#0O^SVOV5O\
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&OJ[*"/_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
